The most appropriate drug used for chelation therapy in beta-thalassemia major is :
**Core Concept**
The question requires knowledge of chelation therapy in the management of beta-thalassemia major, a genetic disorder characterized by impaired hemoglobin synthesis. Chelation therapy is used to remove excess iron from the body, which is accumulated due to frequent blood transfusions.
**Why the Correct Answer is Right**
The most effective chelating agent for beta-thalassemia major is deferiprone (C). It is an oral chelating agent that acts by binding to iron and forming a stable complex, which is then excreted in the urine and feces. Deferiprone has a higher affinity for iron than other chelating agents, making it more effective in reducing body iron stores. This is particularly crucial in patients with beta-thalassemia major, who require frequent blood transfusions and are at risk of developing iron overload.
**Why Each Wrong Option is Incorrect**
* **Option A:** Desferoxamine is an intravenous chelating agent and is not the most suitable option for long-term management of beta-thalassemia major due to its need for parenteral administration.
* **Option B:** Succimer is an oral chelating agent but is primarily used for lead poisoning and not for iron overload in beta-thalassemia major.
* **Option D:** Penicillamine is an oral chelating agent that is used for heavy metal poisoning, including lead, mercury, and arsenic, but is not the preferred choice for iron overload in beta-thalassemia major.
**Clinical Pearl / High-Yield Fact**
Deferiprone is a first-line treatment for iron overload in beta-thalassemia major due to its high efficacy, oral administration, and lower risk of side effects compared to other chelating agents.
**Correct Answer: C. Deferiprone**